A detailed history of Kennebec Savings Bank transactions in Moderna, Inc. stock. As of the latest transaction made, Kennebec Savings Bank holds 26 shares of MRNA stock, worth $994. This represents 0.0% of its overall portfolio holdings.

Number of Shares
26
Holding current value
$994
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$63.64 - $125.14 $1,654 - $3,253
26 New
26 $1.74 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $15B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Kennebec Savings Bank Portfolio

Follow Kennebec Savings Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kennebec Savings Bank, based on Form 13F filings with the SEC.

News

Stay updated on Kennebec Savings Bank with notifications on news.